SG/CALL/EDWARDS LIFESCIENCES/105/0.1/16.01.26 | Market Closed - Boerse Frankfurt Warrants 15:48:33 2024-05-20 EDT | ||
| 1.99 EUR | +1.53% |
|
| Current month | +8.20% | ||
| 1 month | -1.49% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-20 | 1.98 | +1.02% |
| 24-05-17 | 1.96 | -3.45% |
| 24-05-16 | 2.03 | +0.50% |
| 24-05-15 | 2.02 | +9.78% |
| 24-05-14 | 1.84 | +5.75% |
Real-time Boerse Frankfurt Warrants
Last update May 20, 2024 at 03:48 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SW8QXN |
| ISIN | DE000SW8QXN5 |
| Date issued | 2024-04-08 |
| Strike | 105 $ |
| Maturity | 2026-01-16 (606 Days) |
| Parity | 10 : 1 |
| Emission price | 2.38 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.38 € |
|---|---|
| Lowest since issue | 1.68 € |
| Spread | 0.01 € |
| Spread % | 0.50% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.78
USD
Average target price
95.9
USD
Spread / Average Target
+6.82%
- Stock Market
- Warrants
- Warrant
